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Statistical methods for ranking differentially expressed genes In the analysis of microarray data the identification of differential expression is paramount. Here I outline a method for finding an optimal  test statistic with which to rank genes with respect to differential expression. Tests of the method show that it allows generation of top gene  lists that give few false positives and few false negatives. Estimation of the false-negative as well as the false-positive rate lies at the heart  of the method.
Abstract
In the analysis of microarray data the identification of differential expression is paramount. Here I
outline a method for finding an optimal test statistic with which to rank genes with respect to
differential expression. Tests of the method show that it allows generation of top gene lists that
give few false positives and few false negatives. Estimation of the false-negative as well as the false-
positive rate lies at the heart of the method.
Background
Microarray technology has revolutionized modern biological
research by permitting the simultaneous study of genes com-
prising a large part of the genome. The blessings stemming
from this are accompanied by the curse of high dimensional-
ity of the data output. The main objective of this article is to
explore one method for ranking genes in order of likelihood of
being differentially expressed. Top gene lists, that give few
false positives and few false negatives, are the output. As the
interest is mainly in ranking for the purpose of generating top
gene lists, issues such as calculation of p-values and correc-
tion for multiple tests are of secondary importance.
Microarrays have an important role in finding novel drug tar-
gets; the thinking that guides the design and interpretation of
such experiments has been expressed by Lonnstedt and
Speed [1]: "The number of genes selected would depend on
the size, aim, background and follow-up plans of the experi-
ment." Often, interest is restricted to so-called ’druggable’
target classes, thus thinning out the set of eligible genes con-
siderably. It is generally sensible to focus attention first on
druggable targets with smaller p-values (where the p-value is
the probability of obtaining at least the same degree of differ-
ential expression by pure chance) before proceeding to ones
with larger p-values. In general, p-values have the greatest
impact on decisions regarding target selection by providing a
preliminary ranking of the genes. This is not to say that mul-
tiplicity should never be taken into account, or that the meth-
od presented here replaces correction for multiplicity. On the
contrary, the approach provides a basis for such calculations
(see Additional data files).
The approach presented here could be applied to different
types of test statistics, but one particular type of recently pro-
posed statistic will be used. In Tusher [2] a methodology
based on a modified t-statistic is described:
where diff is an effect estimate, for example, a group mean
difference, S is a standard error, and S0 is a regularizing con-
stant. This formulation is quite general and includes, for ex-
ample, the estimation of a contrast in an ANOVA. Setting S0
= 0 will yield a t-statistic. The constant, called the fudge con-
stant, is found by removing the trend in d as a function of S in
moving windows across the data. The technical details are
outlined in [3]. The statistic calculated in this way will be re-
ferred to as SAM. The basic idea with d is to eliminate some
false positives with low values of S, see Figure 1.
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It is more relevant to optimize with respect to false-positive
and false-negative rates. This is the basic idea behind the new
approach. The idea is to jointly minimize the number of genes
that are falsely declared positive and the number of genes
falsely declared negative by optimizing over a range of values
of the significance level a and the fudge constant S0. How well
this is achieved can be judged by a receiver operating charac-
teristics (ROC) curve, which displays the number of false pos-
itives against the number of false negatives expressed as
proportions of the total number of genes.
An alternative to the statistic (1) is d = diff/√(S0
2 + S2), or d =
diff/√(wS0
2 + (1 - w)S2) for some weight w, which is basically
the statistic proposed in Baldi [4]. Its performance appears to
be very similar to that of (1) (data not shown). A software im-
plementation in R code within the package SAG [5,6] is avail-
able from [7] via the function samroc.
Results
The criterion
A comparison of methods in terms of their ROC curves is pre-
sented in Lonnstedt [1]. A method whose ROC curve lies be-
low another one (has smaller ordinate for given abscissa) is
preferred (Figure 2). A method which has a better ROC curve,
in this sense, will produce top lists with more differentially
expressed genes (DEGs), fewer non-DEGs, and, consequent-
ly, will leave out fewer DEGs. Furthermore, such a method
will give higher average ranks to the DEGs, if the ranking is
such that high rank means more evidence of differential ex-
pression. Superiority in terms of average ranks is a weaker as-
sertion than superiority in terms of ROC curves (see
Additional data files for a proof). If it is desirable to compare
methods with respect to their ROC curves, then the estima-
tion procedures should find parameter estimates that opti-
mize the ROC curve. This section suggests a goodness
criterion based on the ROC curve.
False discovery rate (FDR) may be defined as the proportion
of false positives among the significant genes, see [2]. False-
positive rate (FP) may be defined as the number of false pos-
itives among the significant genes divided by the total number
of genes. Similarly, we define the false-negative rate (FN) as
the number of false negatives among the nonsignificant genes
divided by the total number of genes, the true-positive rate
(TP) as the number of true positives divided by the total
number of genes, and, the true-negative rate (TN) as the
number of true negatives divided by the total number of
genes.
In Table 1 relations involving these entities are displayed. For
instance, the proportion of unchanged genes (non-DEGs), p0,
equals the sum of the proportion of true negative and the
Figure 1
The effect of S0. With real microarray data the absolute value of the t-
statistic often shows erratic behavior for small values of the standard 
error S, with an increased risk of false positives. By choosing the constant 
S0 in equation (1) wisely one can alleviate this problem. In the right panel 
we see that the statistic d in equation (1) downplays the importance of 
some of the genes with low standard error, compared to the t-statistic 
(left panel). Data from Golub [16] were used, and S0 was chosen as the 5% 
percentile of S values (see also Discussion).
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Figure 2
ROC curve. This graph displays the number of false negatives (differentially 
expressed genes (DEGs) not included) versus the number of false positives 
(non-DEGs included) found on top lists of increasing sizes, expressed as 
proportions of the total number of genes. The distance C gives an optimal 
value of equation (2). A method whose ROC curve lies below that of 
another method is preferable, as it will give more DEGs and fewer non-
DEGs on any top list of any size, as explained in Additional data. Hence 
method 1 is preferable to method 2.
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proportion of false positive: p0 = TN + FP, and the proportion
of significant genes at a certain significance level α equals the
sum of the true positives and the false positives: p(α) = TP +
FP. It is intuitive that the criterion to be minimized should be
an increasing function of FP and FN. Any top list produced
should have many DEGs and few non-DEGs.
Assume that we can, for every combination of values of the
significance level α and the fudge constant S0, calculate (FP,
FN). The goodness criterion is then formulated in terms of the
distance of the points (FP, FN) to the origin (which point cor-
responds to no false positives and no false negatives, see Fig-
ure 2), which in mathematical symbols may be put as
The optimal value of (α, S0) will be the one that minimizes (2).
It is for practical reasons not possible to do this minimization
over every combination, so the suggestion is to estimate the
criterion over a lattice of (α, S0) values and pick the best
combination.
If one has an assessment regarding the relative importance of
FP and FN, that may be reflected in a version of the criterion
(2) that incorporates a weight λ that reflects the relative im-
portance of FP compared to FN: Cλ = √(λ2 FP2 + FN2). The
choice λ = (1 - p0)/p0 corresponds to another type of ROC
curve, which displays the proportion of true (TP/(1 - p0))
against the proportion of false (FP/p0) (see Additional data
files). Other goodness criteria are possible, such as the sum of
FP and FN or the area under the curve in Figure 2. For more
details and other approaches see, for example [8,9].
Calculating p-values
Using the permutation method to simulate the null distribu-
tion (no change) we can obtain a p-value for a two-sided test,
as detailed below. Loosely speaking, in each loop of the simu-
lation algorithm the group labels are randomly rearranged, so
that random groups are formed, the test statistic is calculated
for this arrangement and the value is compared to the ob-
served one. How extreme the observed test statistic is will be
judged by counting the number of times that more extreme
values are obtained from the null distribution.
The data matrix X has genes in rows and arrays in columns.
Consider the vector of group labels fixed. The permutation
method consists of repeatedly permuting the columns (equiv-
alent to rearranging group labels), thus obtaining the matrix
X*, and calculating the test statistic for each gene and each
permutation. Let d(j)*k be the value of the statistic of the jth
gene in the kth permutation of columns. Then the p-value for
gene i equals
where M is the number of genes, d(i) the observed statistic for
gene i, B the number of permutations and ’#’ denotes the car-
dinality of the set [2,10,11]. In words, this gives the relative
frequency of randomly generated test statistics with an abso-
lute value that exceeds the observed value of gene i. The for-
mula (3) combines the permutation method in [2] and the p-
value calculation in [10]. These p-values are such that a more
extreme value of the test statistic will yield a lower p-value.
Given the significance level α (p-values less than α are consid-
ered significant), the proportion of the genes considered dif-
ferentially expressed is
which is the relative frequency of genes with a p-value less
than α.
The current version of samroc uses the estimate
where qX is the X% percentile of the d* (compare [3]). This es-
timate makes use of the fact that the genes whose test statis-
tics fall in the quartile range will be predominantly the
unchanged ones. More material on this matter is in the Addi-
tional data files.
Estimating FP
Going via results for the FDR in Storey [12] (see also [13,14])
it is possible to derive the estimate
which is the proportion of unchanged genes multiplied by the
probability that such a gene produces a significant result. For
a derivation see the Additional data files.
Table 1
The unknown distribution of true and false positives and 
negatives
Negative Positive
True TN TP
False FN FP
 1 - p(α) p(α)
The proportion of incorrectly called genes equals FN + FP, and the 
proportion called significant equals p(α) = TP + FP.
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Estimating FN
From Table 1 one obtains, as outlined in the Additional data
files,
FN = 1 - p0(1 - α) - p(α)   (6)
To get an intuitive feel for this equality, just note that the sec-
ond term is the proportion unchanged multiplied by the prob-
ability of such genes not being significant, which estimates
TN, and that the third term corresponds to the positive (TP +
FP). Subtracting the proportion of these two categories from
the whole will leave us with the FN.
Estimating the criterion
The entities we need for the optimisation are given by the
estimates
and
A scatter plot of the estimate of the criterion
versus the true value is shown in Figure 3, and reveals a good
level of accuracy.
Tests
A detailed account of the results is given in the Additional
data files, where datasets, data preprocessing, analysis and
results are described in enough detail to enable the results to
be reproduced.
When testing methods in this field it is difficult to find suita-
ble data for which something is known about the true status
of the genes. If one chooses to simulate, then the distributions
may not be entirely representative of a real-life situation. If
one can find non-proprietary real-life data, then the knowl-
edge as to which genes are truly changed may be uncertain. To
provide adequate evidence of good performance it is neces-
sary to provide such evidence under different and reproduci-
ble conditions.
In the comparison, samroc, t-test, Wilcoxon, the Bayesian
method in [1], and SAM [2] were competing. By the t-test I
mean the unequal variance t-test: t = (mean1 - mean2)/√(s1
2/
n1 + s2
2/n2) for sample means mean1 and mean2 and sample
variances s1
2, s2
2. The Wilcoxon rank sum test is based on the
sum Ws of the ranks of the observations in one of the groups
Ws = R1...+ Rn1 [15]. The Bayesian method calculates the pos-
terior odds for genes being changed (available as functions
stat.bay.est.lin in the R package SAG, and stat.bayesian in
the R package sma [1,5]). The method starts from the as-
sumption of a joint a priori distribution of the effect estimate
and the standard error. The former is assumed normal and
the latter inverse Gamma.
Simulated cDNA data
The normal distributions modeled after real-life cDNA data
used in Baldi and Long [4] were used here to provide a testing
ground for the methods (Table 2). In each simulation two
groups of four arrays each were created. Three datasets with
1%, 5% and 10% DEGs were generated using the normal dis-
tributions. In all cases samroc and the t-test coincided (S0 =
0), and were the best methods in terms of the ROC curves.
Theory predicts that the t-test is optimal in this situation (see
Additional data files). When data were antilogarithm-trans-
formed, giving rise to lognormal distributions, samroc again
came out best, followed by the Bayes method. The t-test falls
behind this time. Figure 4 gives a graphical presentation of
the results in terms of ROC curves.
Oligonucleotide leukemia data
The data on two types of leukemia, ALL and AML, appeared
in Golub et al. [16,17]. Samples of both types were hybridized
to 38 arrays. In [17], 50 genes were identified as DEGs using
statistical analysis of data from the full set of arrays. For these
data it is impossible to calculate a ROC curve as the DEGs are
unknown. Instead, performance was assessed in terms of the
average rank of the 50 genes, after all genes were ranked by
their likelihood of being DEGs according to each of the meth-
ods. Using just three arrays from each of the two groups, sam-
roc gave the best results, followed by SAM (Table 3). This
Figure 3
Estimates of the criterion. The true and the estimated value of the 
goodness criterion √(FP2 + FN2). Using data from the simulated cDNA 
distributions, the true FP and FN were calculated and then estimated. 
Finally, the goodness criterion was calculated and displayed in a scatter 
plot, showing a good correspondence between estimate and estimand.
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Figure 4 (see legend on next page)
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means that a necessary but not sufficient condition for the su-
periority of samroc in terms of ROC curves is satisfied (see
Additional data files).
Affymetrix spiking experiment data
In this test, data generated by Affymetrix in an experiment
where 14 transcripts were spiked at known quantities (Table
4) [18,19] were used. Using three arrays from each of two
groups of arrays where 14 probe sets (genes) differ, further
datasets with 140 and 714 DEGs were generated by a boot-
strap procedure. Thus there were three datasets with roughly
0.1%, 1% and 5% DEGs. In two of these three settings samroc
performed best, and in one case (0.1%) SAM and the Bayes
method were better. Figure 5 gives a graphical presentation of
these results in terms of ROC curves.
Discussion
Whether to look at data on a log scale or not is a tricky ques-
tion, and is beyond the scope of this article. However, the best
performance by the tests considered was achieved when data
were lognormal (see Additional data files). Normal, lognor-
mal and real-life data were all included in order to supply a
varied testing ground.
As pointed out in [20], the Bayes statistic is for ranking pur-
poses equivalent to a penalized t-statistic  tp  = (mean1  -
mean2)/√(a1 + S2). Here a1 is a scale parameter related to the
a priori distribution of the standard error. This means that it
is, at least in form, closely related to the t-test, SAM and sam-
roc. SAM, on the other hand, chooses as its fudge constant the
value among the percentiles of S, which minimizes the coeffi-
cient of variation of the median absolute deviation of the test
statistic computed over a number of percentiles of S [3]. It is
interesting to note how different the three related statistics
the Bayes method, SAM and samroc turn out in practice.
One clue to why this difference occurs emerges when compar-
ing the denominators of SAM/samroc and Bayes more close-
ly. First square the denominators of (1) and the
representation of Bayes above. We obtain (a + S)2 = a2 + 2aS
+ S2 for (1) and a1 + S2 for Bayes (where generally a1 ≥  a2). For
large values of S the former will exceed the latter. This means
that SAM/samroc will downplay the importance of the results
for high expressing genes in a way that the Bayes method does
not.
But there is also another difference. The Bayes method seems
to achieve best when the number of false positives is allowed
to grow rather large. The constant a corresponds to a large
percentile in the distribution of the S2 values (see Additional
data files). Whereas the constant in SAM will generally be
rather small, often the 5-10% percentile of the S values, the
constant in the Bayes method will correspond to at least the
40% percentile of the S2 values. It seems that using a large
percentile will give a good performance when the number of
false positives grows large. This observation is consistent with
the observation made in Lonnstedt and Speed [1] that the par-
ticular version of SAM, which always uses the 90% percentile,
will pass the Bayes method when the number of false posi-
tives is allowed to grow large. Also, samroc will in general
make use of a smaller percentile, albeit that samroc shows
greater spread between datasets in the values chosen, as a re-
sult of its adaptation to the features specific to the data at
hand.
Samr oc is  th e o nly  met ho d th at  mak es  ex plici t u se  of t he
number of changed genes in the ranking. If one has reason to
believe, for example from studying expression (3), that there
are very few DEGs (<< 1%), then samroc is probably not the
first choice. Probably SAM or the Bayes method is more
Figure 4 (see previous page)
Simulated normal and log-normal data. (a) Normal distribution, 1% DEGs. As expected with independent normally distributed observations, the t-test will 
perform quite well, and is matched by samroc, which in this case equals the equal-variance t-test. The Bayes method has problems with these data, with SAM 
and Wilcoxon somewhere in between these extremes. (b) Lognormal distribution, 1% DEGs. samroc may have a slight advantage for shorter lists, whereas 
the Bayes method is better for longer lists, where the number of false positives is larger. The other three methods lag behind, but not by much. (c) Normal 
distribution, 5% DEGs. The t-test and samroc coincide; samroc is now equivalent to the equal-variance t-test, which behaves in the same way as the unequal-
variance t-test in this case. (d) Lognormal distribution, 5% DEGs. The difference between methods is less when data are exponentiated. However, samroc has 
the edge for a wide range of cutoffs, but the Bayes method catches up when more genes are selected. The other three methods are struggling to avoid last 
spot. (e) Normal distribution, 10% DEGs. Again the samroc and the t-test coincide and the Bayes method has problems with normal data. SAM is also lagging 
behind, while the other three are very close together. (f) Lognormal distribution, 10% DEGs. samroc comes out well; Wilcoxon has the worst performance, 
SAM and the t-test are scarcely better, while the Bayes method is intermediate.
Table 2
The normal distributions simulated defined by their means and 
standard deviations
Mean1 sd1 Mean2 sd2
-8 0.2 -8 0.2
-10 0.4 -10 0.4
-12 1.0 -12 1.0
-6 0.1 -6.1 0.1
-8 0.2 -8.5 0.2
-10 0.4 -11 0.7
The first three rows do not represent differential expression, while the 
last three rows do.http://genomebiology.com/2003/4/6/R41 Genome Biology 2003,     Volume 4, Issue 6, Article R41       Broberg  R41.7
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useful in these situations. If, on the other hand, the number of
DEGs is reasonably large, samroc is conjectured to take prec-
edence over SAM, and to be more robust than the Bayes
method. Furthermore, one can argue that the kind of experi-
ments undertaken in drug discovery would more often than
not end in comparisons in which the biological systems show
vast differences in a large number of genes, mostly as a down-
stream effect of some shock to the system.
The proposed method comes out better than or as good as the
original SAM statistic in most tests performed. The samroc
statistic is robust and flexible in that it can address all sorts of
problems that suit a linear model. The methodology adjusts
the fudge constant flexibly and achieves an improved per-
formance. The algorithm gives fewer false positives and fewer
false negatives in many situations, and was never much worse
than the best test statistic in any circumstance. However, a
typical run with real-life data will take several hours on a
desktop computer. To make this methodology better suited
for production it would be a good investment to translate part
of the R code, or the whole of it, into C.
To improve on standard univariate tests one must make use
of the fact that data are available on a large number of related
tests. One way of achieving this goal has been shown in this
paper. The conclusion is that it is possible and sensible to cal-
ibrate the test with respect to estimates of the false-positive
and false-negative rates.
Additional data files
A zip file (Additional data file 1) containing the R package
SAG for retrieval, preparation and analysis of data from the
Affymetrix GeneChip and the R script (Additional data file 2)
are available with the online version of this article. An appen-
dix (Additional data file 3) giving further details of the statis-
tical methods and the samroc algorithm is also available as a
PDF file.
Figure 5
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Figure 5
Spike data. (a) Spike data with 14 DEGs. Three arrays from each group in 
the Affymetrix spike experiment were used. The granularity of Wilcoxon 
shows up here as a lack of performance, and at this sample size Wilcoxon 
is not an option. SAM starts off optimistically, and then falls back when the 
lists become longer and the false positives more, and samroc and Bayes 
catch up with it. In particular, the latter performs strongly. (b) Spike data 
with 154 DEGs. The spike data with an added 140 changed genes obtained 
from adding permuted residuals to group means for the 14 spiked genes, 
generating three arrays per group. This makes the percentage of DEGs 
just above 1%. We see that samroc improves considerably compared to 
(a), and now shows the best performance for a wide range of top list sizes. 
(c) Spike data with 714 DEGs. The spike data with an added 700 changed 
genes obtained from adding permuted residuals to group means for the 14 
spiked genes, generating three arrays per group. This makes the 
percentage DEGs just above 5%. Now samroc takes the lead, and when the 
false positives reach roughly 10%, it is passed by the Bayes method. This 
point corresponds to a top list of roughly 1,400.R41.8 Genome Biology 2003,     Volume 4, Issue 6, Article R41       Broberg  http://genomebiology.com/2003/4/6/R41
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The table shows the part of the design of the Affymetrix spike 
experiment used as a testing ground for methods of ranking genes with 
respect to differential expression. Out of the 12,626 probe sets on the 
U95A array 14 transcripts have been spiked at known quantities in 
picomols selected according to a Latin square design. Here 
'experiment' (M, N, O..., T) refers to a set of three arrays with the 
same spiking. The numbers indicate the amount of spike transcript in 
pM.
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